HCW Biologics Inc.
HCWB | NASDAQ
$1.91
+$0.04 (+2.14%)
At close: Sep 21, 2026, 4:00 PM ET
$1.97
+$0.06 (+3.07%)
Pre-market:
Sep 22, 2026, 4:38 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 54.23K | 2.57M | 2.84M | 6.72M | n/a | 4.1M |
Cost of Revenue | 43.39K | 1.61M | 2.28M | 4.14M | n/a | n/a |
Gross Profit | 10.85K | 959.4K | 560.36K | 2.59M | n/a | 4.1M |
Operating Income | -11.26M | -29.48M | -25.72M | -15.08M | -13.37M | -5.82M |
Interest Income | n/a | n/a | n/a | n/a | 505.37K | 22.32K |
Pretax Income | -7.96M | -30.02M | -24.99M | -14.9M | -12.86M | -5.8M |
Net Income | -7.96M | -30.02M | -24.99M | -14.9M | -12.86M | -5.78M |
Selling & General & Admin | 7.7M | 21.95M | 13.08M | 7.99M | 5.3M | 2.44M |
Research & Development | 5.44M | 6.39M | 7.68M | 9.34M | 8.17M | 7.26M |
Other Expenses | -1.88M | 2.1M | 5.52M | 338.46K | -108K | 233.04K |
Operating Expenses | 11.27M | 30.44M | 26.28M | 17.67M | 13.37M | 9.92M |
Interest Expense | 1.25M | 1.16M | 283.04K | 126.66K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | 208.46K | n/a |
Cost & Expenses | 11.31M | 32.05M | 28.56M | 21.8M | 13.37M | 9.92M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 349.62K | 6.47M | 5.99M | 5.97M | 5.96M | 6.12M |
Shares Outstanding (Diluted) | 349.62K | 6.47M | 5.99M | 5.97M | 5.96M | 6.12M |
EPS (Basic) | -63.78 | -4.62 | -4.20 | -2.52 | -2.16 | -0.96 |
EPS (Diluted) | -63.78 | -4.62 | -4.20 | -2.52 | -2.16 | -0.96 |
EBITDA | -5.67M | -27.68M | -23.58M | -14.06M | -12.32M | -5.25M |
EBIT | -6.71M | -28.87M | -24.71M | -14.77M | -12.86M | -5.82M |
Depreciation & Amortization | 1.04M | 1.18M | 1.14M | 717.85K | 543.6K | 572.87K |
Add to Watchlist
Select watchlists to add or remove HCWB